Temporary FDA Advisory Committee Members, Recommendations, and Agency Actions, 2017-2021.
作者信息
Chaudhry Nikhil, Zhang Audrey D, Schwartz Jason L, Ramachandran Reshma, Ross Joseph S
机构信息
Collaboration for Regulatory Rigor, Integrity, and Transparency, Yale School of Medicine, New Haven, Connecticut.
Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
出版信息
JAMA Netw Open. 2024 Oct 1;7(10):e2436789. doi: 10.1001/jamanetworkopen.2024.36789.
Abstract
摘要
相似文献
1
Temporary FDA Advisory Committee Members, Recommendations, and Agency Actions, 2017-2021.2017 - 2021年美国食品药品监督管理局临时咨询委员会成员、建议及机构行动
JAMA Netw Open. 2024 Oct 1;7(10):e2436789. doi: 10.1001/jamanetworkopen.2024.36789.
2
Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.2008-2015 年，食品和药物管理局顾问委员会建议与机构行动之间的关联。
Milbank Q. 2019 Sep;97(3):796-819. doi: 10.1111/1468-0009.12403. Epub 2019 Jul 14.
3
FDA advisory committees: their purpose, how they work, and how you can become a member.
Am J Gastroenterol. 2006 Apr;101(4):689-91. doi: 10.1111/j.1572-0241.2006.00573.x.
4
Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021.2010-2021 年，咨询委员会投票与美国食品和药物管理局处方药决策的关联。
JAMA Health Forum. 2023 Jul 7;4(7):e231718. doi: 10.1001/jamahealthforum.2023.1718.
5
Advisory committee; Pediatric Advisory Committee; establishment. Final Rule.咨询委员会；儿科咨询委员会；设立。最终规则。
Fed Regist. 2004 Aug 2;69(147):46098-9.
6
Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.美国食品药品监督管理局的咨询委员会：欣奇修正案与“利益冲突”豁免
J Health Law. 2006 Fall;39(4):415-49.
7
Revisiting financial conflicts of interest in FDA advisory committees.重新审视美国食品药品监督管理局咨询委员会中的利益冲突问题。
Milbank Q. 2014 Sep;92(3):446-70. doi: 10.1111/1468-0009.12073.
8
Group says FDA, advisory panels show bias toward drug approvals.该组织称，美国食品药品监督管理局及顾问小组在药物审批上表现出偏袒。
Washington Post. 2006 Aug 29:A13.
9
Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.肿瘤药物咨询委员会的建议和美国食品药品监督管理局对癌症药物的批准。
JAMA Oncol. 2016 Jun 1;2(6):744-50. doi: 10.1001/jamaoncol.2015.6479.
10
Discrepancies Between US Food and Drug Administration Vaccine Licensure Indications and Advisory Committee on Immunization Practices Recommendations: Provider Knowledge and Attitudes.美国食品和药物管理局疫苗许可适应症与免疫实践咨询委员会建议之间的差异：提供者的知识和态度。
Clin Ther. 2018 Aug;40(8):1308-1319.e16. doi: 10.1016/j.clinthera.2018.07.004. Epub 2018 Aug 11.
本文引用的文献
1
Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021.2010-2021 年，咨询委员会投票与美国食品和药物管理局处方药决策的关联。
JAMA Health Forum. 2023 Jul 7;4(7):e231718. doi: 10.1001/jamahealthforum.2023.1718.
2
Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.2008-2015 年，食品和药物管理局顾问委员会建议与机构行动之间的关联。
Milbank Q. 2019 Sep;97(3):796-819. doi: 10.1111/1468-0009.12403. Epub 2019 Jul 14.
Zotero 插件